Publicacións en colaboración con investigadores/as de University of Lorraine (1)

2022

  1. Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

    The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 4, pp. 294-306